Filing Details

Accession Number:
0001140361-20-026656
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-25 20:11:56
Reporting Period:
2020-11-19
Accepted Time:
2020-11-25 20:11:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1228627 Ocuphire Pharma Inc. OCUP Pharmaceutical Preparations (2834) 113516358
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1557832 Cam Gallagher C/O Ocuphire Pharma, Inc.
37000 Grand River Ave, Suite 120
Farmington Hills MI 48335
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-11-19 8,865 $0.00 23,354 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Warrant (right to buy) Acquisiton 2020-11-19 13,394 $0.00 13,394 $4.48
Common Stock Series B Warrant (right to buy) Acquisiton 2020-11-19 1,574 $0.00 1,574 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
13,394 2020-11-19 2025-11-19 No 4 P Direct
1,574 2020-11-19 2022-01-28 No 4 P Direct
Footnotes
  1. The Reporting Person purchased shares, Series A Warrants and Series B Warrants as part of a private placement for an aggregate price of $50,000.
  2. Subject to adjustment based on certain price reset provisions.